BRCA1 and atherosclerosis: For example, BRCA1 and CRISP2 specific site methylation changes are associated with atherosclerosis, indicating that differentially methylated regions of BRCA1 and CRISP2 emerge as biomarkers for CVD (Istas et al., 2017).